Your browser doesn't support javascript.
loading
Targeting the TCA cycle through cuproptosis confers synthetic lethality on ARID1A-deficient hepatocellular carcinoma.
Xing, Tao; Li, Li; Chen, Yiran; Ju, Gaoda; Li, Guilan; Zhu, Xiaoyun; Ren, Yubo; Zhao, Jing; Cheng, Zhilei; Li, Yan; Xu, Da; Liang, Jun.
Afiliação
  • Xing T; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Li L; Department of Oncology, Peking University International Hospital, Beijing 102206, China.
  • Chen Y; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China.
  • Ju G; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Li G; Department of Pathology, Peking University International Hospital, Beijing 102206, China.
  • Zhu X; Department of Pathology, Peking University International Hospital, Beijing 102206, China.
  • Ren Y; Department of Pathology, Peking University International Hospital, Beijing 102206, China.
  • Zhao J; Department of Pathology and Neuropathology, University Hospital Tübingen, 72074 Tübingen, Germany.
  • Cheng Z; Department of Hepatobiliary Surgery, Peking University International Hospital, Beijing 102206, China.
  • Li Y; Department of Hematology, Peking University International Hospital, Beijing 102206, China.
  • Xu D; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Hepatopancreatobiliary Surgery Department I, Peking University Cancer Hospital & Institute, Beijing 100142, China. Electronic address: daxu@bjmu.edu.cn.
  • Liang J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China; Department of Oncology, Peking University International Hospital, Beijing 102206, China. Electronic address: liangjun1959@aliyun.com.
Cell Rep Med ; 4(11): 101264, 2023 11 21.
Article em En | MEDLINE | ID: mdl-37939712

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apoptose / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Cell Rep Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apoptose / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Cell Rep Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China